Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Invested Capital (2016 - 2026)

Tenax Therapeutics' Invested Capital history spans 7 years, with the latest figure at $8.9 million for Q4 2017.

  • On a quarterly basis, Invested Capital fell 48.18% to $8.9 million in Q4 2017 year-over-year; TTM through Dec 2017 was $8.9 million, a 48.18% decrease, with the full-year FY2017 number at $8.9 million, down 48.18% from a year prior.
  • Invested Capital hit $8.9 million in Q4 2017 for Tenax Therapeutics, down from $10.2 million in the prior quarter.
  • Over the last five years, Invested Capital for TENX hit a ceiling of $82.9 million in Q2 2014 and a floor of -$1.8 million in Q2 2013.
  • Historically, Invested Capital has averaged $30.8 million across 5 years, with a median of $15.6 million in 2016.
  • Biggest five-year swings in Invested Capital: tumbled 413.81% in 2013 and later surged 4759.94% in 2014.
  • Tracing TENX's Invested Capital over 5 years: stood at -$1.8 million in 2013, then surged by 4759.94% to $82.9 million in 2014, then fell by 27.07% to $60.4 million in 2015, then tumbled by 71.63% to $17.1 million in 2016, then plummeted by 48.18% to $8.9 million in 2017.
  • Business Quant data shows Invested Capital for TENX at $8.9 million in Q4 2017, $10.2 million in Q3 2017, and $11.3 million in Q2 2017.